Machine learning-coupled combinatorial mutagenesis enables resource-efficient engineering of CRISPR-Cas9 genome editor activities.
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: The primary study couples machine-learning-guided combinatorial mutagenesis with experimental screening and structural/wet-lab validation to engineer Cas9 variants with increased activity. This is a specific genome-editor engineering result, with the assays and cell contexts bounding the claim.
Technology: PMC full Methods/Results: candidate search reduced by about 95%, top-hit enrichment about 7.5×, followed by validation of N888R/A889Q KKH-SaCas9 and derived base editor in human cells. First publication date from PMC 2022-04-25.
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
- AI contribution
- PMC full Methods/Results: candidate search reduced by about 95%, top-hit enrichment about 7.5×, followed by validation of N888R/A889Q KKH-SaCas9 and derived base editor in human cells. First publication date from PMC 2022-04-25.
- Limitation / still unknown
- Results are limited to the reported models, cohorts, datasets or experiments; broader generalization and clinical or operational benefit were not established.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC9039034/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.